ATR and ovarian cancer: CX-5461 has been shown to activate ATM/ATR (ataxia telangiectasia and RAD3 related) signaling and a G2/M cell cycle checkpoint in ovarian cancer (OVCA) cells with differential sensitivities observed across a panel of 32 OVCA cell lines (Sanij et al., 2020).